Bone Biologics

BBLG

0.39482.66% ( -0.0108 )

Closed: Oct 23, 16:00:01 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Bone Biologics(BBLG) the EBIT is -808.11 K (-8.02%), Beat estimate;the EPS is -0.43 (+67.67%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITExceed expectations

-0.00B8.02%

-0.00B8.88%

+0.00B0.86%

EPSMiss expectations

-0.4367.67%

-0.3970.68%

-0.04003.01%

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 13, 2026

Estimate Revenue0

Estimate EBIT-819.28 K

Estimate EPS-0.19

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly